The AI Overuse Problem
When testosterone replacement therapy became more widely available through private clinics, aromatase inhibitors (AIs) — specifically anastrozole — became standard co-prescription for many men. The logic seemed straightforward: testosterone converts to oestrogen via aromatase, more testosterone means more oestrogen, so add an AI to control it.
The reality is more nuanced. Over-prescription of anastrozole is one of the most common causes of poor TRT outcomes. Men who are prescribed an AI they don't need end up with crashed oestrogen — which produces symptoms as bad as, or worse than, the high oestrogen they were trying to prevent.
Understanding when an AI is indicated, when it isn't, and what to do about oestrogen on TRT is essential for anyone managing their own protocol or evaluating what their clinic prescribes.
What Aromatase Does and Why Oestrogen Matters in Men
Aromatase is an enzyme found in fat tissue, brain, liver, and other tissues. It converts androgens (primarily testosterone and androstenedione) into oestrogens (primarily oestradiol). In men, approximately 80% of circulating oestradiol comes from peripheral aromatisation of testosterone.
Oestrogen in men is not the enemy. This is the fundamental misunderstanding that drives AI overuse.
Oestradiol in men is essential for:
- Libido — oestradiol is a significant driver of male sexual desire, working alongside testosterone
- Bone density — oestradiol is the primary driver of bone maintenance in men (more so than testosterone directly)
- Cardiovascular health — oestradiol has vasodilatory and cardioprotective effects
- Brain function — oestradiol influences mood, memory, and cognitive function
- Joint health — oestradiol lubricates joints and reduces inflammation in connective tissue
- Body composition — oestradiol helps regulate fat distribution and insulin sensitivity
Oestradiol that is too high relative to testosterone causes problems. Oestradiol that is too low — which is what AIs cause — also causes serious problems. The goal is balance, not elimination.
When High Oestradiol Is Actually a Problem on TRT
High oestradiol becomes symptomatic when it rises significantly — particularly when the testosterone:oestradiol ratio is unfavourable. Typical symptoms:
- Water retention (bloating, puffy face, soft appearance)
- Nipple sensitivity or tenderness (early gynecomastia signal)
- Mood instability, irritability, or emotional flatness
- Reduced libido (counterintuitive but real — high oestrogen can reduce libido despite being important for it at normal levels)
- Headaches
The key distinction: symptoms and numbers together, not numbers alone. Some men tolerate oestradiol of 180 pmol/L with no symptoms. Others feel symptomatic at 140 pmol/L. The threshold is individual.
The reference range context: Most UK labs quote oestradiol reference range for men as 41–159 pmol/L. On TRT with elevated testosterone, oestradiol naturally rises above this range. Values of 160–250 pmol/L are common and often well-tolerated. The question is always symptomatic picture first, lab value second.
When High Oestrogen Is Not an AI Problem — It's a Dose Problem
The most important principle in TRT oestrogen management: high oestrogen on TRT is almost always a sign that testosterone dose is too high, not that an AI is needed.
Oestrogen is proportional to testosterone. Raise testosterone, oestrogen follows. If testosterone is pushed well above the physiological range (above 35–40 nmol/L), oestrogen will be proportionally elevated. The correct response is to reduce the testosterone dose, not to add a drug that suppresses oestrogen independently.
Clinics that reflexively add anastrozole when oestradiol rises — without considering whether the testosterone dose itself is appropriate — are creating unnecessary complexity and risk.
What Crashed Oestrogen Feels Like
Over-suppression of oestrogen with AIs is one of the most miserable hormonal states a man can experience, and it's entirely iatrogenic (medically caused). Symptoms:
Joint pain: The most diagnostic symptom. Oestradiol lubricates joints. Crash it and joints become painful — wrists, knees, hips, elbows. Men describe it as feeling 20 years older overnight.
Severe loss of libido: More complete than high-oestrogen libido reduction. Low oestradiol causes near-total loss of sexual interest and function.
Erectile dysfunction: Oestradiol is needed for nitric oxide-mediated erection mechanisms. Crashed oestrogen causes ED that doesn't respond to TRT and may not respond to PDE5 inhibitors.
Brain fog and cognitive impairment: Severe low oestradiol produces marked cognitive dulling — difficulty thinking, poor memory, inability to concentrate.
Mood: flat, depressed, empty. Described by men who've experienced it as the most psychologically dark state they've been in — worse than the low testosterone they started TRT to address.
Fatigue: Similar to low testosterone fatigue but different quality — more hollow, less motivated.
If you're on TRT with an AI and experiencing these symptoms, check oestradiol. Values below 70–80 pmol/L with symptoms suggest over-suppression.
Anastrozole: What It Is and How It Works
Anastrozole (brand name Arimidex) is a non-steroidal aromatase inhibitor — it reversibly blocks aromatase enzyme activity. At 0.5–1mg per day (the typical TRT co-prescription dose), it reduces oestradiol by 50–80%.
The problem with these doses on standard TRT: A man on 125mg testosterone cypionate per week with normal aromatase activity may have oestradiol naturally settling at 130–160 pmol/L — entirely manageable without intervention. Adding 0.5mg anastrozole three times per week will crash that oestradiol to below 70 pmol/L. This is over-suppression.
The dose-response relationship of anastrozole is steep. Very small doses (0.125mg or 0.25mg twice weekly) may be appropriate for men who genuinely need some oestrogen management. The 0.5–1mg daily doses historically prescribed are usually far too aggressive.
Exemestane: The Alternative AI
Exemestane (Aromasin) is a steroidal AI — it irreversibly binds aromatase. Its action is more predictable, it has a mildly androgenic structure (derived from androstenedione), and some evidence suggests it's less likely to produce the rebound oestrogen elevation that can occur when anastrozole is stopped.
Some clinicians prefer exemestane at low doses (6.25mg, 1–2× weekly) over anastrozole for TRT oestrogen management. Not universally available in UK private TRT, but an option worth asking about.
The Current Best Practice: AI Only If Needed
The evolution of TRT clinical practice in the UK and US has moved decisively toward:
- Start at conservative testosterone dose (100–125mg per week) that keeps testosterone in physiological range rather than supraphysiological
- Allow oestradiol to settle without intervention
- Assess symptomatic picture at 6–8 weeks — symptoms of high oestrogen are the primary indicator, not the absolute oestradiol number
- If oestradiol is genuinely elevated and symptomatic: consider dose reduction first; add low-dose AI only if symptoms persist despite dose optimisation
- If AI used: start very low (0.125–0.25mg anastrozole 1–2× per week) and adjust based on both symptoms and bloodwork
The BSSM (British Society for Sexual Medicine) guidelines and the position of most experienced TRT clinicians now reflects that AI use should be limited to men with clear symptomatic and biochemical indication — not routine co-prescription.
Monitoring: What to Test and When
Before starting TRT: Baseline oestradiol (plus full hormone panel).
At 6–8 weeks: Oestradiol trough (48 hours after last injection, before the next). This is the lowest oestradiol point in the injection cycle and reflects true trough levels.
If AI added: Recheck oestradiol 4–6 weeks after any AI dose change. The goal is to keep oestradiol above 70–80 pmol/L, preferably 80–130 pmol/L, in a symptomatic man with previously elevated oestradiol.
Ongoing: Every 3–6 months alongside testosterone, haematocrit, and PSA.
Quick Reference: High vs. Low Oestrogen on TRT
| Symptom | High Oestrogen | Low Oestrogen (Crashed) | |---------|---------------|------------------------| | Water retention | Yes | No | | Nipple sensitivity | Yes | No | | Joint pain | No | Yes (significant) | | Libido | Reduced | Very low / absent | | Mood | Emotional, irritable | Flat, empty, depressed | | Cognitive | Foggy | Severely foggy | | ED | Possible | Common, severe |
If you're on TRT with an AI and feel worse than you did before TRT — check oestradiol. The problem may be the AI.
The Short Version
Oestrogen in men is not the enemy — it's essential for libido, bones, cardiovascular health, joints, and mood. AIs (anastrozole, exemestane) are only indicated when oestradiol is genuinely elevated AND symptomatic. Most high-oestradiol situations on TRT are better addressed by reducing testosterone dose than adding an AI. Crashed oestrogen from over-use of AIs causes severe joint pain, mood destruction, cognitive impairment, and complete loss of libido — often worse than the original low-testosterone problem. If AI is used, start with the lowest effective dose (0.125–0.25mg anastrozole 1–2× weekly) and titrate based on symptoms and bloods.